WELCOME TO G-FINDER

G-FINDER tracks public, private, and philanthropic funding of basic research and product development (R&D) for global health priorities.

The core focus of the project is neglected disease (ND) R&D funding. NDs are diseases that predominantly affect low- and middle-income countries and for which products are needed, but there is insufficient commercial incentive to stimulate R&D.

The survey also collects data about R&D funding for emerging infectious diseases (EIDs). The list of diseases included in the survey is based on the priority pathogens identified in the WHO R&D Blueprint.

This year, we are also inviting participants to provide data on their R&D funding for sexual and reproductive health (SRH) issues. The SRH issues included in the survey were identified as high priority areas by a group of international experts. The SRH survey is separate to the ND/EID survey, but accessible on the same platform.

Please provide data for both the ND/EID and the SRH surveys, if applicable.

The surveys are conducted by Policy Cures Research and funded by the Bill & Melinda Gates Foundation. For more information, please refer to the frequently asked questions.




G-FINDER reports

The neglected disease survey results are published and launched as yearly G-FINDER reports (see below). Data collected for other global health priorities will be reported separately:

- the EID survey results (analysing 2014-2017 funding data) will be published in June 2019, coinciding with the Global Health Security Conference in Sydney. We hope to publish EID funding data collected for 2018 at a later stage

- the SRH survey results (analysing 2018 funding data) will be published in early 2020.



G-FINDER neglected disease reports from previous years:

2018. Neglected Disease Research & Development: Reaching new heights

2017. Neglected Disease Research & Development: Reflecting on a decade of global investment

2016. Neglected Disease Research & Development: A pivotal moment for global health

2015. Neglected Disease Research & Development: The Ebola effect

2014. Neglected Disease Research & Development: Emerging trends

2013. Neglected Disease Research & Development: The public divide

2012. Neglected Disease Research & Development: A five year review

2011. Neglected Disease Research & Development: Is innovation under threat?

2010. Neglected Disease Research & Development: Is the global financial crisis changing R&D

2009. Neglected Disease Research & Development: New times, new trends

2008. Neglected Disease Research & Development: How much are we really spending?


G-FINDER Public Search Tool

All underlying data is freely available via the G-FINDER public search tool. Confidential industry data is aggregated and anonymised.


Key dates


14 June 2019
Deadline for completing the survey

SURVEY OPEN

December 2019
Publication and global launch of the twelfth annual report


25 days left to complete the survey.

SURVEY OPEN